ScreenerHero
BVXPBioventix PLC
LSE · GB · Healthcare · Biotechnology · bioventix.com
1800.00GBP+7.46%Mkt Cap: 120.63M $P/E: 12.77

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertilit…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5
ARWR
Arrowhead Pharmaceuticals, Inc.
$12.59BUSD

Key Statistics

Company
Market Cap120.63M $
Enterprise Value113.83M $
Revenue (TTM)16.09M $
Gross Profit15.28M $
Net Income (TTM)9.73M $
Revenue/Share3.080 USD
Last Price1800.00 GBP
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees12
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)12.77
P/E (Forward)0.10
PEG—
EV/EBITDA9.02
EV/Revenue7.08
P/S7.49
P/B8.50
EPS (TTM)1.41
EPS (Forward)179.30
52W Range
0.000071% of range2550.00
52W High2550.00 GBP
52W Low0.0000 GBP
Profitability
Gross Margin90.86%
Oper. Margin76.56%
EBITDA Margin78.45%
Profit Margin57.83%
ROE65.66%
ROA58.96%
Growth
Revenue Growth-8.50%
Earnings Growth-3.90%
Cash Flow & Leverage
Operating CF9.02M $
CapEx (TTM)24.61K $
FCF Margin52.59%
FCF Yield7.01%
Net Debt-6.80M $
Net Debt/EBITDA-0.54
Balance Sheet
Debt/Equity—
Current Ratio6.12
Quick Ratio5.76
Book Value/Sh2.113 GBP
Cash/Share1.015 GBP
Dividends
Fwd Div Rate1.500 GBP
Trail. Div Rate1.500 GBP
Div. Yield8.96%
5Y Avg Yield4.70%
Payout Ratio106.75%
Ex-Div DateApr 9, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3900.00 GBP
Upside (mean)+116.7%
Target Range3900.00 GBP – 3900.00 GBP
# Analysts1
Ownership
Shares Out.5.22M
Float4.15M
Insiders7.70%
Institutions64.89%
Technical
SMA 501591.20 (+13.1%)
SMA 2001694.88 (+6.2%)
Beta0.54
S&P 52W Chg18.16%
Avg Vol (30d)9.40K
Avg Vol (10d)9.04K
Technical Indicators
RSI (14)78.0
MACD10.4335
MACD Signal-21.1557
MACD Hist.+31.5892
BB Upper1687.42 GBP
BB Middle1539.40 GBP
BB Lower1391.38 GBP
BB Width19.23%
ATR (14)112.39 GBP
Vol Ratio (20d)0.84x